Haloperidol Decanoate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Haloperidol Decanoate Injection (injection) from Fresenius Kabi USA, LLC with status To Be Discontinued. The shortage was first posted on Jan 9, 2026.
Shortage details
- Status
- To Be Discontinued
- Company
- Fresenius Kabi USA, LLC
- Package NDC
- 63323-469-01
- Dosage Form
- Injection
- Presentation
- Haloperidol Decanoate, Injection, 50 mg/1 mL (NDC 63323-469-01)
- Initial Posting
- Jan 9, 2026